Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

Australia

Austria

Belgium

Brazil *

Canada

China *

Denmark

Finland

France

Germany

Hong Kong *

India *

Ireland

Italy

Japan *

Luxembourg

Mexico *

Netherlands

Norway

Philippines *

Republic of Korea *

Singapore *

Spain

Sweden

Switzerland

Thailand *

United Kingdom

United States

Infographic

Gene insertion technologies for cell line development

Utilizing the right tools for cell line development is essential for creating consistent and high-quality biotherapeutics. One of these key tools is the gene insertion technology used, either random or transposon-based integration. But which should you be using for your biotherapeutic workflow and is it worth switching from your current technology?

To help answer this question we’ve created an infographic that demonstrates the 3 pillars of productivity that will have you making the positive switch from random to transposon-based integration.

Improved efficiency
Enhanced stability
Increased consistency

The CHOSOURCE Platform is available for research, clinical, diagnostic, and commercialization applications, including services, under specific licenses from Revvity.

To view the full content please answer a few questions

Have a sales representative contact me

First Name

Last Name

Country

Email Address

Company

Zip / Postal Code

Business Phone

Role

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Download Resource

Gene insertion technologies for cell line development

Download Infographic